Evidence map›Paper›PMID 30603551›Full record

ReviewTissue engineering and regenerative medicine2018

Stem Cell Tracing Through MR Molecular Imaging.

Rasoul Yahyapour, Bagher Farhood, Ghazale Graily, Abolhasan Rezaeyan, Saeed Rezapoor, Hamid Abdollahi, Mohsen Cheki, Peyman Amini, Hengameh Fallah, Masoud Najafi and 1 more

Abstract readReview
In one paragraph

Review in Tissue engineering and regenerative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. CellularInternational journal of molecular sciences · 2023
    Article
  2. Article
  3. Review
  4. Brain & spine · 2022
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Molecular imaging in tracking cancer stem cells: A review.Medical journal of the Islamic Republic of Iran · 2020
    Review
  17. Review
  18. Multimodal Composite Iron Oxide Nanoparticles for Biomedical Applications.Tissue engineering and regenerative medicine · 2019
    Review
  19. Updates in molecular imaging techniques.Tissue engineering and regenerative medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rasoul YahyapourSchool of Medicine, Jiroft University of Medical Sciences, Jiroft, 8813833435 Iran.
Bagher Farhood2Department of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan, 3715835155 Iran.
Ghazale Graily3Department of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, 1417613151 Iran.
Abolhasan Rezaeyan4Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, 1449614535 Iran.
Saeed Rezapoor5Department of Radiology, Faculty of Paramedical, Tehran University of Medical Sciences, Tehran, 1417613151 Iran.
Hamid Abdollahi4Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, 1449614535 Iran.
Mohsen Cheki6Department of Radiologic Technology, Faculty of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, 6135715794 Iran.
Peyman Amini5Department of Radiology, Faculty of Paramedical, Tehran University of Medical Sciences, Tehran, 1417613151 Iran.
Hengameh Fallah7Department of Chemistry, Faculty of Science, Islamic Azad University, Arak, 3836119131 Iran.
Masoud Najafi8Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Science, Kermanshah, 6714869914 Iran.
Elahe Motevaseli9Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, 194193311 Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cell therapy opens a new window in medicine to overcome several diseases that remain incurable. It appears such diseases as cardiovascular disorders, brain injury, multiple sclerosis, urinary system diseases, cartilage lesions and diabetes are curable with stem cell transplantation. However, some questions related to stem cell therapy have remained unanswered. Stem cell imaging allows approval of appropriated strategies such as selection of the type and dose of stem cell, and also mode of cell delivery before being tested in clinical trials. MRI as a non-invasive imaging modality provides proper conditions for this aim. So far, different contrast agents such as superparamagnetic or paramagnetic nanoparticles, ultrasmall superparamagnetic nanoparticles, fluorine, gadolinium and some types of reporter genes have been used for imaging of stem cells. The core subject of these studies is to investigate the survival and differentiation of stem cells, contrast agent's toxicity and long term following of transplanted cells. The promising results of

Indexed as

Cell therapyMolecular imagingMRIRegenerative medicineStem cell

Identifiers

PMID30603551
PMCPMC6171680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.